Browsing publications by Dr Hilary Wynne

Newcastle AuthorsTitleYearFull text
Salah Abohelaika
Professor Farhad Kamali
Dr Peter Avery
Dr Patrick Kesteven
Dr Hilary Wynne
et al.
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England2014
Salah Abohelaika
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
C0170: The Impact of Dietary Vitamin K on the Pharmacological Activity of FXa Inhibitor Rivaroxaban in Man2014
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
Lilian Fairbairn Smith
Dr Wei Cope
Professor Farhad Kamali
Dr Hilary Wynne
Effect of provision of the NHS NPSA oral anticoagulant therapy patient information pack upon patients' knowledge and anticoagulant control2011
Professor Farhad Kamali
Dr Hilary Wynne
Pharmacogenetics of warfarin2010
Professor Farhad Kamali
Dr Hilary Wynne
Pharmacogenetics and anticoagulation therapy2009
Dr Ellen Hatch
Dr Hilary Wynne
Dr Peter Avery
Professor Farhad Kamali
Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients2008
Elizabeth Sconce
Dr Hilary Wynne
Professor Farhad Kamali
Factors Affecting Anticoagulation Response to Warfarin2008
Elizabeth Sconce
Dr Peter Avery
Dr Hilary Wynne
Professor Farhad Kamali
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake: A pilot study2008
Dr Ellen Hatch
Elizabeth Sconce
Dr Barry King
Dr Hilary Wynne
Professor Ann Daly
et al.
Polymorphisms in genes associated with the vitamin K epoxide reductase complex do not affect warfarin dose requirement2007
1234